All News about Gilead Sciences
Via Talk Markets
$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today
February 23, 2024
Via Benzinga
Gilead Sciences to Present at Upcoming Investor Conferences
February 20, 2024
Via Business Wire
Analysts see over 50% gains in these 2 mid-cap biotech stocks
February 14, 2024
Via MarketBeat
Topics
Artificial Intelligence
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
From Brodsky & Smith LLC
Via GlobeNewswire
Via Benzinga
Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Exposures
Product Safety
Via Business Wire
Gilead Sciences Stock Approaches Daily Buying Area
February 12, 2024
Via Talk Markets
Exposures
COVID-19
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
February 11, 2024
Via Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.